Aeglea Biotherapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $1.1M | 49k | 23.28 |
2024-09-30 | $778k | 26k | 29.41 |
2024-06-30 | $708k | 30k | 23.51 |
More positions owned by Ubs Global Asset Management Americas
Home Depot (HD)
View all positions for Ubs Global Asset Management Americas